Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems

Finger, Robert; Daien, Vincent; Eldem, Bora; Talks, James; Korobelnik, Jean-Francois; Mitchell, Paul; Sakamoto, Taiji; Wong, Tien; Pantiri, Krystallia; Carrasco, Joao

doi:10.1186/s12886-020-01554-2

Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems

Atıf İçin Kopyala

Finger R. P. , Daien V., Eldem B. M. , Talks J. S. , Korobelnik J., Mitchell P., ...Daha Fazla

BMC OPHTHALMOLOGY, cilt.20, 2020 (SCI İndekslerine Giren Dergi)

Cilt numarası: 20 Konu: 1
Basım Tarihi: 2020
Doi Numarası: 10.1186/s12886-020-01554-2
Dergi Adı: BMC OPHTHALMOLOGY

Özet

Background: Systematically review the evidence describing the impact of anti-vascular endothelial growth factor (anti-VEGF) therapy on neovascular age-related macular degeneration (nAMD) patient outcomes and healthcare resource utilization.